论文部分内容阅读
目的:研究分析对小儿肺炎支原体感染后气道高反应患者的临床治疗和护理效果。方法:回顾性分析2011年3月-2013年3月期间,我院收治的100例肺炎支原体感染后气道高反应患儿的临床资料,根据患儿治疗期间采用的不同治疗和护理措施将其分为两组,对照组患儿50例,住院期间给予常规治疗和一般护理干预,观察组患儿50例,在常规治疗的基础上加用孟鲁斯特纳治疗,并加强临床综合护理,比较两组患儿的临床疗效和护理效果。结果:治疗后观察组患儿的各项临床指标明显优于对照组,组间比较差异明显具有统计学意义,(P<0.05)。结论:对小儿肺炎支原体感染后气道高反应患者采用孟鲁斯特纳治疗能够显著改善患儿的临床症状,缩短治疗时间,提高患者的治疗效果和护理满意度,具有重要的临床价值,值得重视和推广。
Objective: To study the clinical effect and nursing effect on airway hyperresponsiveness in children with Mycoplasma pneumoniae infection. Methods: The clinical data of 100 children with airway hyperresponsiveness after mycoplasma pneumoniae infection were retrospectively analyzed from March 2011 to March 2013 in our hospital. According to the different treatment and nursing measures adopted during treatment, Divided into two groups, the control group of 50 children, given routine treatment and general nursing intervention during hospitalization, observation group of 50 children, on the basis of conventional treatment with montelukastone treatment, and to strengthen clinical comprehensive nursing, The clinical efficacy and nursing effect of two groups were compared. Results: After treatment, the clinical indexes of the observation group were significantly better than those of the control group. The differences between the two groups were statistically significant (P <0.05). CONCLUSIONS: It is of great clinical value to use Montelukast to treat patients with airway hyperresponsiveness after pneumonia mycoplasma infection, which can significantly improve the clinical symptoms, shorten the treatment time, improve the treatment effect and satisfaction of the patients Emphasis and promotion.